Celetrix Electroporation specializes in advanced electroporation technologies that cater to a variety of applications, including CAR-T and CAR-NK cell therapies, genome editing, antibody production, and stem cell research. Their innovative electroporation systems, such as the Model SLT (Single Large Tube) and Model EX+, are designed to efficiently process large volumes of cells, achieving high transfection efficiencies. The Model SLT can electroporate up to 2x10^9 CHO cells in a single 10ml tube, facilitating rapid antibody production with significant yields in a short timeframe. Additionally, Celetrix's unique electroporation tube design eliminates the inefficiencies and cell death associated with traditional cuvettes, enhancing overall performance.

The company also offers specialized kits, such as the THP-1 helper kit, which supports plasmid electroporation in monocytic cell lines, further broadening the scope of their technology. Celetrix's systems are compatible with various cell types, including primary cells and stimulated T, B, and NK cells, and they provide tailored modes for different applications, ensuring optimal conditions for each cell type. With a focus on both small and large-scale applications, Celetrix Electroporation aims to deliver high efficiency and reproducibility in cell manipulation, making it a valuable resource for researchers in the fields of biotechnology and medicine.

United States

Celetrix is the leader in electroporation with our new high efficiency electroporation technologies for delivering DNA, RNA and proteins to cells. Celetrix provides technology and support for CAR-T manufacturing by transposon mediated expression and RNP mediated gene editing for T cells, stem cells and CD34+ HSC.

Celetrix Electroporation

Company Details